Can you please direct me to literature/research on Cymbalta and Effexor in breastfeeding women, specifically that address the infant dose received and transfer into breastmilk?
Announcement
Collapse
No announcement yet.
Welcome to our forum! Before posting your questions, please read the following terms:
- 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
- 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
- 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
- 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.
By posting to the forums, you acknowledge and agree to these terms.
The InfantRisk team
Cymbalta and Effexor 3 months postpartum and breastfeeding
Collapse
X
-
Cymbalta Papers:
Lobo ED, Loghin C, Knadler MP et al. Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women. Clin Pharmacokinet. 2008;47:103-109.
Briggs GG, Ambrose PJ, Ilett KF, Hackett LP, Nageotte MP, Padilla G. Use of duloxetine in pregnancy and lactation. Ann Pharmacother. Nov 2009;43(11):1898-1902.
Boyce PM, Hackett LP, Ilett KF. Duloxetine transfer across the placenta duringpregnancy and into milk during lactation. Arch Womens Ment Health 2011;14(2):169-72.
Effexor Papers:
Ilett KF, Kristensen JH, Hackett LP, Paech M, Kohan R, Rampono J. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002; 53(1):17-22.
Newport DJ, Ritchie JC, Knight BT, Glover BA, Zach EB, Stowe ZN. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure. J Clin Psychiatry. Sep 2009;70(9):1304-1310.
Tran MM, Fancourt N, Ging JM et al. Failure to thrive potentially secondary to maternal venlafaxine use. Australas psychiatry 2016;24(1):98-9.
Koren G, Moretti, Kapur B. Can Venlafaxine in Breast Milk Attenuate the Norepinephrine and Serotonin Reuptake Neonatal Withdrawal Syndrome? JOGC 2006 April; 28(4):299-302.
Comment